Mathias Muth

Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity

Johannes Antony, Kerstin Kellershohn, Marion Mohr‐Andrä et al. · The FASEB Journal · 2008 · 150 citations

Drug Target, Molecular Biology, Chemical Biology +21

Design, Synthesis, and Action of Oxotremorine-Related Hybrid-Type Allosteric Modulators of Muscarinic Acetylcholine Receptors

Teresa Disingrini, Mathias Muth, Clelia Dallanoce et al. · Journal of Medicinal Chemistry · 2005 · 71 citations · Full text

Dynamic ligand binding dictates partial agonism at a G protein–coupled receptor

Andreas Böck, Brian Chirinda, Fabian Krebs et al. · Nature Chemical Biology · 2013 · 50 citations

Molecular Pharmacology, Molecular Physiology, Signal Transduction +11

Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor‐positive, human epidermal growth factor receptor 2‐negative locally advanced or metastatic breast cancer: Results of the single‐arm, phase IIIB 4EVER trial

Hans Tesch, Oliver J. Stoetzer, Thomas Decker et al. · International Journal of Cancer · 2018 · 42 citations · Full text

Metastatic Breast Cancer, Oncology, Breast Oncology +13

Antitrypanosomal activity of quaternary naphthalimide derivatives

Mathias Muth, Verena Hoerr, Melanie Glaser et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 30 citations

Derivative (Chemistry), Chemical Derivative, Biomolecular Engineering +1